WINZOR PHARMACEUTICALS UK LIMITED

Company Registration Number:
07533771 (England and Wales)

Unaudited statutory accounts for the year ended 28 February 2022

Period of accounts

Start date: 1 March 2021

End date: 28 February 2022

WINZOR PHARMACEUTICALS UK LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2022

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

WINZOR PHARMACEUTICALS UK LIMITED

Directors' report period ended 28 February 2022

The directors present their report with the financial statements of the company for the period ended 28 February 2022

Principal activities of the company

The company's principal activity continues to be that of export pharmaceutical products



Directors

The directors shown below have held office during the whole of the period from
1 March 2021 to 28 February 2022

MR TAGHUB AL-KASS
Ms DANA AL-KASS
TARA AL-KASS


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
9 September 2022

And signed on behalf of the board by:
Name: MR TAGHUB AL-KASS
Status: Director

WINZOR PHARMACEUTICALS UK LIMITED

Profit And Loss Account

for the Period Ended 28 February 2022

2022 2021


£

£
Turnover: 1,905,000 3,014,540
Cost of sales: ( 784,261 ) ( 1,600,720 )
Gross profit(or loss): 1,120,739 1,413,820
Administrative expenses: ( 979,698 ) ( 1,092,567 )
Operating profit(or loss): 141,041 321,253
Profit(or loss) before tax: 141,041 321,253
Tax: ( 26,798 ) ( 55,908 )
Profit(or loss) for the financial year: 114,243 265,345

WINZOR PHARMACEUTICALS UK LIMITED

Balance sheet

As at 28 February 2022

Notes 2022 2021


£

£
Fixed assets
Tangible assets: 3 804,961 804,961
Total fixed assets: 804,961 804,961
Current assets
Stocks: 4 496,705 220,191
Debtors: 5 192,690 87,691
Cash at bank and in hand: 294,609 608,177
Total current assets: 984,004 916,059
Creditors: amounts falling due within one year: 6 ( 170,911 ) ( 217,209 )
Net current assets (liabilities): 813,093 698,850
Total assets less current liabilities: 1,618,054 1,503,811
Creditors: amounts falling due after more than one year: 7 ( 486,258 ) ( 486,258 )
Total net assets (liabilities): 1,131,796 1,017,553
Capital and reserves
Called up share capital: 99 99
Profit and loss account: 1,131,697 1,017,454
Total Shareholders' funds: 1,131,796 1,017,553

The notes form part of these financial statements

WINZOR PHARMACEUTICALS UK LIMITED

Balance sheet statements

For the year ending 28 February 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 September 2022
and signed on behalf of the board by:

Name: MR TAGHUB AL-KASS
Status: Director

The notes form part of these financial statements

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Turnover policy

    The turnover represents the total amount receivable by the Company in the ordinary course of business with outside customers for goods supplied as a principal excluding Value Added Tax

    Tangible fixed assets depreciation policy

    Depreciation is not provided on the fixed assets

    Other accounting policies

    Stock is stated at the lower of cost or net realisable value calculated on a first in first out basis

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

  • 2. Employees

    2022 2021
    Average number of employees during the period 49 47

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 March 2021 334,109 470,852 804,961
Additions
Disposals
Revaluations
Transfers
At 28 February 2022 334,109 470,852 804,961
Depreciation
At 1 March 2021
Charge for year
On disposals
Other adjustments
At 28 February 2022
Net book value
At 28 February 2022 334,109 470,852 804,961
At 28 February 2021 334,109 470,852 804,961

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

4. Stocks

2022 2021
£ £
Stocks 496,705 220,191
Total 496,705 220,191

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

5. Debtors

2022 2021
£ £
Trade debtors 192,690 87,691
Total 192,690 87,691

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

6. Creditors: amounts falling due within one year note

2022 2021
£ £
Trade creditors 144,113 161,301
Taxation and social security 26,798 55,908
Total 170,911 217,209

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2022

7. Creditors: amounts falling due after more than one year note

2022 2021
£ £
Other creditors 486,258 486,258
Total 486,258 486,258